Trademarks owned by Bristol-Myers Squibb Company | Applied Marks - Trademark, Domain Name and Social Media Protection for Brands - /\\\ Applied Marks
Search | Trademarks | International | Pricing
owned Bristol-Myers Squibb Company owned Bristol-Myers Squibb Company
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9

Trademarks owned by 'Bristol-Myers Squibb Company'

Summary of page content
88805781
2020-02-21
US
Bristol-Myers Squibb Company
OPDUALAG NIVOLUMAB/RELATLIMAB)
Trademark Image
The mark consists of The mark consists of the term "OPDUALAG" with a curved line over it and the term ("NIVOLUMAB/RELATLIMAB") below it.
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use
  • 44
    Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
    health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awareness and pharmaceuticals; providing a website featuring educational information in the field of healthcare and pharmaceutical preparations
616
REVIVED - AWAITING FURTHER ACTION
2021-04-09
2021-04-10
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
77941220
2010-02-22
3845228
2010-09-07
US
Bristol-Myers Squibb Company
SPRYCEL
Trademark Image
The mark consists of the word "SPRYCEL" in stylized lettering and a dot over the letter "Y" and a line underneath.
  • 16
    Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
    printed matter, namely, booklets, brochures, pamphlets and newsletters on the subject of cancer
710
CANCELLED - SECTION 8
2021-04-09
2021-04-09
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
87603446
2017-09-11
US
Bristol-Myers Squibb Company
I'M BREATHING BECAUSE
  • 9
    Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus.
    audio and video recordings about health care and pharmaceuticals; downloadable video recordings featuring information about health care, pharmaceuticals and lung cancer
  • 41
    Education; providing of training; entertainment; sporting and cultural activities
    educational services, namely, conducting programs in the field of health care, pharmaceuticals and oncology
  • 44
    Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
    health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues and health awareness; providing medical information in the field of lung cancer; providing pharmaceutical information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of lung cancer and pharmaceutical preparations for the prevention or treatment of lung cancer
732
THIRD EXTENSION - GRANTED
2021-02-10
2021-04-09
life air living systems easy space disorders bag fire body enhancement stresseraser system asthma glorious circuit awareness week services belly
88659971
2019-10-18
US
Bristol-Myers Squibb Company
OPDIVO ALLAYZ
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
681
PUBLICATION/ISSUE REVIEW COMPLETE
2021-03-23
2021-04-07
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
88660403
2019-10-18
US
Bristol-Myers Squibb Company
ALLAYZ
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
681
PUBLICATION/ISSUE REVIEW COMPLETE
2021-03-23
2021-04-07
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
88681679
2019-11-06
US
Bristol-Myers Squibb Company
ZENCEIVE
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use for immunotherapy, including t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
686
PUBLISHED FOR OPPOSITION
2021-04-06
2021-04-06
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
88937218
2020-05-28
US
Bristol-Myers Squibb Company
RILTYKTRA
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use for immunotherapy, namely t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
686
PUBLISHED FOR OPPOSITION
2021-04-06
2021-04-06
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
88937251
2020-05-28
US
Bristol-Myers Squibb Company
ADVRANO
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use for immunotherapy, namely t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
686
PUBLISHED FOR OPPOSITION
2021-04-06
2021-04-06
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
88946834
2020-06-03
US
Bristol-Myers Squibb Company
SULIBRA
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use for immunotherapy, namely t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
686
PUBLISHED FOR OPPOSITION
2021-04-06
2021-04-06
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
88946846
2020-06-03
US
Bristol-Myers Squibb Company
OPDIVO SULIBRA
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use for immunotherapy, namely t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
686
PUBLISHED FOR OPPOSITION
2021-04-06
2021-04-06
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
90076369
2020-07-27
US
Bristol-Myers Squibb Company
MITYTRAV
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use for immunotherapy, namely t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
686
PUBLISHED FOR OPPOSITION
2021-04-06
2021-04-06
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
77523432
2008-07-16
4122104
2012-04-03
US
Bristol-Myers Squibb Company
DASISION
  • 42
    Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
    medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
702
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
2018-03-31
2021-04-03
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
88130488
2018-09-25
US
Bristol-Myers Squibb Company
POSSIBILITY LIVES
  • 41
    Education; providing of training; entertainment; sporting and cultural activities
    business education and training services in the nature of a behavioral and communications educational program which utilizes neuroscience research to foster and improve innovation and business results
732
THIRD EXTENSION - GRANTED
2021-04-01
2021-04-03
power every art reality life = green endless realm gp greater paper choice living social work purpose culture transforming potential
88681638
2019-11-06
US
Bristol-Myers Squibb Company
OPDIVO ZENCEIVE
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use for immunotherapy, including t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
641
NON-FINAL ACTION - MAILED
2021-04-03
2021-04-03
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
87537822
2017-07-21
US
Bristol-Myers Squibb Company
ALAGNIVO
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
734
FIFTH EXTENSION - GRANTED
2021-04-01
2021-04-02
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
87635191
2017-10-05
US
Bristol-Myers Squibb Company
BEQSTIAT
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
734
FIFTH EXTENSION - GRANTED
2021-04-01
2021-04-02
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
87645790
2017-10-14
US
Bristol-Myers Squibb Company
ZATAREY
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
734
FIFTH EXTENSION - GRANTED
2021-04-01
2021-04-02
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
87645793
2017-10-14
US
Bristol-Myers Squibb Company
VALZOREY
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
734
FIFTH EXTENSION - GRANTED
2021-04-01
2021-04-02
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
87645797
2017-10-14
US
Bristol-Myers Squibb Company
VALZORAY
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
734
FIFTH EXTENSION - GRANTED
2021-04-01
2021-04-02
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
87645798
2017-10-14
US
Bristol-Myers Squibb Company
DAKMELA
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
734
FIFTH EXTENSION - GRANTED
2021-04-01
2021-04-02
bristol myers care community health hope d2 reliability uniformity purity efficacy bms virology bridging cancer foundation center fitness learners delivering
First 1 2 3 4 5 6 7 8 9 10  > Last  1 of 212
NEED HELP? Chat with us online
Search
Trademarks
Domain Names
Social Media
Compare brands
Browse
All trademarks
iPhone, Nike, Twitter
Google, Pfizer, Microsoft
Register
Trademarks
International Trademarks
Domain Names
Social Media
Company registration
Brand Services
Management
Partner (Reseller or Affiliate)
About Us
About
Contact

Copyright 2008 - 2024 Applied Marks Pty Ltd (ACN 134 698 249). All rights reserved. Terms of Service, Privacy Policy and Acceptable Use Policy.